Non-peptide &dgr; opioid agonists and antagonists

By Dondio G.   Ronzoni S.   Petrillo P.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1075-1098

Informa Healthcare

Access to resources Recommend Favorite

The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors

By Hatzoglou A.   Bakogeorgou E.   Castanas E.  

European Journal of Pharmacology, Vol. 296, Iss. 2, 1996-01 ,pp. : 199-207

Elsevier

Access to resources Recommend Favorite

Rational design of peptide agonists of cell-surface receptors

By Taylor S.I.S.I.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 1, 2000-01 ,pp. : 9-10

Elsevier

Access to resources Recommend Favorite

Relative efficacies of -opioid receptor agonists at the cloned human -opioid receptor

By Quock R.M.   Hosohata Y.   Knapp R.J.   Burkey T.H.   Hosohata K.   Zhang X.   Rice K.C.   Nagase H.   Hruby V.J.   Porreca F.   Roeske W.R.   Yamamura H.I.  

European Journal of Pharmacology, Vol. 326, Iss. 1, 1997-05 ,pp. : 101-104

Elsevier

Access to resources Recommend Favorite

Differential binding properties of oripavines at cloned - and -opioid receptors

By Lee K.O.   Akil H.   Woods J.H.   Traynor J.R.  

European Journal of Pharmacology, Vol. 378, Iss. 3, 1999-08 ,pp. : 323-330

Elsevier

Access to resources Recommend Favorite